Page last updated: 2024-10-21

urea and Carcinoma 256, Walker

urea has been researched along with Carcinoma 256, Walker in 14 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" After 12 days of treatment, the tumor growth, some parameters of cachexia/anorexia, the blood levels of triacylglycerol, glucose, lactate and urea, the peripheral response to insulin and the hepatic glycolysis and gluconeogenesis were investigated."3.79Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats. ( Bazotte, RB; Borba-Murad, GR; da Rocha, AF; de Morais, H; de Souza, CO; de Souza, HM; Miksza, DR, 2013)
"Celecoxib was administered daily (5-50 mg/kg body weight) beginning at the day in which the tumour cells were inocculated."1.34Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats. ( Acco, A; Alves da Silva, MH; Batista, MR; Bracht, A; Yamamoto, NS, 2007)
"The urea cycle was evaluated in perfused livers isolated from cachectic tumor-bearing rats (Walker-256 tumor)."1.32The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats. ( Bracht, A; Constantin, J; Corbello Pereira, SR; da Silva, MH; Darronqui, E; Yamamoto, NS, 2004)
"The strain of Walker carcinosarcoma 256 described induces hypercalcaemia, hyperphosphataemia and hyperuraemia in tumour bearing rats."1.25The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. ( Bellwinkel, S; Minne, H; Raue, F; Ziegler, R, 1975)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19907 (50.00)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martins, HA1
Bazotte, RB4
Vicentini, GE1
Lima, MM1
Guarnier, FA1
Hermes-Uliana, C1
Frez, FC1
Bossolani, GD1
Fracaro, L1
Fávaro, LD1
Manzano, MI1
Zanoni, JN1
Miksza, DR1
de Souza, CO2
de Morais, H2
da Rocha, AF1
Borba-Murad, GR3
de Souza, HM3
Rebeca, R1
Bracht, L1
Noleto, GR1
Martinez, GR1
Cadena, SM1
Carnieri, EG1
Rocha, ME1
de Oliveira, MB1
Cassolla, P2
Moreira, CC2
Liboni, TF1
Zaia, CT1
Dornellas, AP1
Corbello Pereira, SR1
Darronqui, E1
Constantin, J1
da Silva, MH1
Yamamoto, NS2
Bracht, A2
Acco, A1
Alves da Silva, MH1
Batista, MR1
Cates, LA1
Minne, H1
Raue, F1
Bellwinkel, S1
Ziegler, R1
Levin, VA1
Freeman-Dove, M1
Landahl, HD1
DeWys, WD1
Baker, BR1
Siebenneick, HU1
Tarnowski, GS1
Cappuccino, JG1
Schmid, FA1
Green, S1

Other Studies

14 other studies available for urea and Carcinoma 256, Walker

ArticleYear
l-Glutamine supplementation promotes an improved energetic balance in Walker-256 tumor-bearing rats.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3

    Topics: Animals; Blood Glucose; Cachexia; Carcinoma 256, Walker; Corticosterone; Dietary Supplements; Duoden

2017
Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Blood Glucose; Cachexia; C

2013
Production of cachexia mediators by Walker 256 cells from ascitic tumors.
    Cell biochemistry and function, 2008, Volume: 26, Issue:6

    Topics: Animals; Arginase; Ascitic Fluid; Biogenic Polyamines; Cachexia; Carcinoma 256, Walker; Cell Line, T

2008
Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake.
    Cell biochemistry and function, 2012, Volume: 30, Issue:4

    Topics: Animals; Anorexia; Cachexia; Carcinoma 256, Walker; Cholesterol; Fatty Acids, Nonesterified; Glycero

2012
Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.
    International journal of experimental pathology, 2013, Volume: 94, Issue:1

    Topics: Alanine; Animals; Carcinoma 256, Walker; Cell Proliferation; Gluconeogenesis; Glucose; Glycerol; Liv

2013
The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats.
    Biochimica et biophysica acta, 2004, Apr-05, Volume: 1688, Issue:3

    Topics: Alanine; Ammonia; Animals; Cachexia; Carcinoma 256, Walker; In Vitro Techniques; Kinetics; Liver; Ma

2004
Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:5

    Topics: Alanine; Ammonia; Animals; Arginine; Carcinoma 256, Walker; Celecoxib; Cyclooxygenase 2 Inhibitors;

2007
Phosphorus-nitrogen compounds. VII. Urea, aziridinecarboxamide, and semicarbazide derivatives.
    Journal of medicinal chemistry, 1967, Volume: 10, Issue:5

    Topics: Amides; Animals; Antimalarials; Antineoplastic Agents; Azirines; Carcinoma 256, Walker; Leukemia L12

1967
The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256.
    Acta endocrinologica, 1975, Volume: 78, Issue:3

    Topics: Animals; Body Weight; Bone and Bones; Calcium; Carcinoma 256, Walker; Female; Hypercalcemia; Kidney;

1975
Permeability characteristics of brain adjacent to tumors in rats.
    Archives of neurology, 1975, Volume: 32, Issue:12

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Neoplasms; Capillary Permeability; Carcinoma

1975
A spectrum of organ systems that respond to the presence of cancer. Abnormalities of taste as a remote effect of a neoplasm.
    Annals of the New York Academy of Sciences, 1974, Volume: 230

    Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Disease Models, Animal; Food Preferences; Hum

1974
Irreversible enzyme inhibitors. 185. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride. 2.
    Journal of medicinal chemistry, 1971, Volume: 14, Issue:9

    Topics: Aminohydrolases; Anilides; Animals; Benzene Derivatives; Carcinoma 256, Walker; Chlorine; Ethers; Fl

1971
Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Cancer research, 1967, Volume: 27, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Female;

1967
The effect of 1, 3-bis(2-chloroethyl)-nitrosourea on nicotinamide adenine dinucleotide glycohydrolase of mouse and rat neoplastic and normal tissues.
    Cancer research, 1966, Volume: 26, Issue:12

    Topics: Animals; Brain; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Intestines; Kidney; Liver; Lung; Mi

1966